Shwetha Rupendu
Internal Medicine · Rocky Mount, NCNPI 1467004366
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AstraZeneca at 31.3% of the total. Reporting peaked in 2021 at $1,009 and has fallen 98.6% since, to $14 in 2025.
Across 85 payments — averaging $33.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$892
- Johnson & Johnson$734
- Novo Nordisk$142
- E.r. Squibb & Sons, L.L.C.$133
- Gilead$120
- Kiniksa Pharmaceuticals, Ltd.$105
- plus $721 from 16 others
What the payments were for
- Food & beverage$2,847100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 27 | $892 |
| Johnson & Johnson | 13 | $734 |
| Novo Nordisk | 2 | $142 |
| E.r. Squibb & Sons, L.L.C. | 5 | $133 |
| Gilead | 6 | $120 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $105 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $99 |
| AbbVie | 4 | $98 |
| Boston Scientific | 1 | $97 |
| Boehringer Ingelheim | 6 | $97 |
| Bayer | 4 | $80 |
| Pfizer | 3 | $46 |
| Paratek Pharmaceuticals, Inc. | 2 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Bioxcel Therapeutics, Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Teleflex LLC | 1 | $20 |
| Incyte Corporation | 1 | $18 |
| Karyopharm Therapeutics Inc. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
| GSK | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,847 in reported general payments places this provider in the 85th percentile of 3,302 internal medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amlodipine Besylate | 40 | $277 |
| Cephalexin | 18 | $124 |
| Furosemide | 27 | $111 |
| Pantoprazole Sodium | 20 | $106 |
| Metoprolol Succinate | 19 | $91 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $78 |
| Doxycycline Hyclate | 17 | $76 |
| ClopidogrelClopidogrel Bisulfate | 13 | $64 |
| Losartan Potassium | 15 | $58 |
| Atorvastatin Calcium | 18 | $45 |
| Prednisone | 27 | $39 |
| Carvedilol | 13 | $37 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Rocky Mount
- Nirmish ShahDurham$862K
- Eugene WrightFayetteville$839K
- Saad UsmaniCharlotte$551K
- Bhakti PaulRaleigh$536K
- Mary KlotmanDurham$478K
- Manesh PatelDurham$435K
- Millie LongChapel Hill$374K
- Marc JohnsonCharlotte$342K
- Christina CraterRaleigh$330K
- Jamy ArdWinston Salem$293K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.